Come up with a name for your new list and we'll add to it:
ImevaX raised a round of funding on October 14, 2014. Investors include
Bundesministerium fur Bildung und Forschung.
ImevaX is a biopharmaceutical company founded in 2014 based in Munich/Germany. The company is a spin-out of Technische Universitat Munchen (TUM) and sponsored with funds from the German Ministry of Ed…